Compassionate Use in Oman
How the compassionate use pathway operates in Oman.
About Compassionate Use
A regulatory pathway allowing seriously ill patients access to investigational or unregistered drugs.
How Compassionate Use works in Oman
Oman's MoH operates a personal-import pathway; volumes are smaller but the pathway is functional for rare-disease and specialty needs.
Patients in Oman seeking access under Compassionate Use typically follow this flow: a licensed physician in Oman issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Oman
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.